methyl (3R,4S)-4-(4-chlorophenyl)pyrrolidine-3-carboxylate hydrochloride, 97.0%, 100mg

2-{4-[2-(2-Methoxyethoxy)ethoxy]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95+%, 100mg

1-(4-chloro-3-nitrophenyl)-3-(ethoxycarbonyl)-5-methyl-4,5-dihydro-1H-pyrazole-5-carboxylic acid, 95.0%, 1g

4-(4-Fluorophenyl)-6-isopropyl-2-(N-methyl-N-methanesulfonylamino)-5-pyrimidinecarboxaldehyde>98.0%(HPLC)(N)25g

3-(DIBUTYLAMINO)PHENOL, 95%, 500g

N-Boc-2-Amino-5-bromopyrimidine, 95.0%, 10g

(R)-5-Bromomethyl-2-pyrrolidinone, 95.0%, 5g

tert-Butyl 7-oxo-5-thia-2-azaspiro[3.4]octane-2-carboxylate, 95%, 2g

Perrhenic acid, solution (Hydroxotrioxorhenium(VII) solution) 5 g

Ethyl 4-hydroxyphenylacetate, 96.0%, 100g

Methyl 1-(5-bromopyrimidin-2-yl)cyclopropanecarboxylate, 95.0%, 250mg

6-Amino-1-benzyl-1H-pyrimidine-2,4-dione, 10g

3-(4-Benzyl-1-piperidinyl)propanoic acid, 95+%, 1g